You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

January 7, 2015

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

CDC: Flu reaches "epidemic" level

After 21 children died from complications associated with the flu this season, the Centers for Disease Control and Prevention (CDC) declared the illness an "epidemic." » The number of states reporting a high amount of “flu-like” illness activity has risen

Pharmacy-hospital partnership reduces readmissions among CHF patients

Desert Regional Medical Center, Palm Springs, California, reduced readmission rates by 17% among congestive heart failure (CHF) patients through a close partnership with Desert Hospital Outpatient Pharmacy. » Here are the keys to success

Continuing Education

MTM essentials for smoking cessation

This month's CE activity is part of a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to assist pharmacists in providing smoking cessation services for patients interested in quitting smoking..

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 14DT13-KCE28.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

FDA approves ivermectin 1% cream for rosacea

FDA approved Soolantra (ivermectin) Cream 1% (Galderma) for the treatment of rosacea in December 2014. The once-daily topical has been shown in studies to be an effective, safe treatment for inflammatory lesions of papulopustular rosacea. » Details

 

RELATED ARTICLES

FDA approves first IV flu medication

Investigational drug may change course of patients with heart failure

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group